Cognitive Dysfunction: all 3,930 studies

Page 39 of 40. Open to participants first (1,114), then studies with results posted, then the rest; newest registration first within each.

• Critical Illness Myopathy as a Cause of Debilitating ICU-Acquired WeaknessActive, not recruitingNCT00937001Not applicable
• Donepezil and the Risk of Falls in Seniors With Cognitive ImpairmentCompletedNCT00934531Not applicable
• CORonary Diet Intervention With Olive Oil and Cardiovascular PREVentionCompletedNCT00924937Not applicable
• Establishment of a Bank of Biospecimens for Future Research on Age-related Cognitive DisordersCompletedNCT00911690
• Does APOE-e4 Predict Delirium and Cognitive Dysfunction After Surgery?CompletedNCT00911677
• Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)CompletedNCT00908999
• The Difference in Postoperative Cognitive Dysfunction and Myocardial Ischemia Between Propofol and IsofluraneStatus unknownNCT00908518
• Cognitive Impairment in Kidney DiseaseCompletedNCT00905619
• Evolution of Memory Related ActivityStatus unknownNCT00902499
• Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged PopulationCompletedNCT00901355
• The Role Of Cognitive Impairment In The Use Of The Diskus InhalerCompletedNCT00891059
• Cognitive Function After Stem Cell TransplantationStatus unknownNCT00884338Phase 3
• A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric ConditionsCompletedNCT00870974Phase 1
• A Study of Intrathecal Enzyme Therapy for Cognitive Decline in MPS ICompletedNCT00852358Not applicable
• Postoperative Cognitive Decline, Inflammation, and Plasma Levels of Beta-amyloidsCompletedNCT00850928
• Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder, Depressed Type: Prevalence and Improvement With Treatment of Depressive SymptomsCompletedNCT00844974Not applicable
• Trial of Simvastatin in Amnestic Mild Cognitive Impairment (MCI) PatientsStatus unknownNCT00842920Phase 4
• Cognitive Impairment in Patients With Heart FailureCompletedNCT00837889
• Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy VolunteersCompletedNCT00785759Phase 2
• Incidence and Predictors of Delirium After Cardiac SurgeryCompletedNCT00784576
• Energy Metabolism and Cognitive AgingCompletedNCT00777010Not applicable
• Septic Encephalopathy and Late Cognitive DysfunctionCompletedNCT00772096Phase 4
• n-3 Enriched Nutrition Therapy and Postoperative Cognitive Dysfunction After Cardiac SurgeryTerminatedNCT00757913Phase 4
• Efficacy of Fish Oil Supplementation on Cognition in MCI Patients and the Influence of the APOE4 AlleleCompletedNCT00746005Not applicable
• A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With SchizophreniaWithdrawnNCT00743847Phase 2
• Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy SubjectsCompletedNCT00743405Phase 1
• Pharmacogenetic Study for Topiramate-Induced Cognitive DysfunctionStatus unknownNCT00731900
• Depth of Anaesthesia and Cognitive DysfunctionCompletedNCT00719628
• Carbon Dioxide Insufflation on Cerebral MicroemboliTerminatedNCT00715845Phase 2/3
• Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On CognitionTerminatedNCT00704327
• Effect of Usage of Electroencephalogram (EEG) Entropy on the Incidence of Postoperative Cognitive Dysfunction in Geriatric PatientsTerminatedNCT00700674
• Vitamin B12 and Folic Acid Supplementation for Preventing Fractures in Elderly PeopleStatus unknownNCT00696514Phase 1
• The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's DiseaseStatus unknownNCT00696215Phase 4
• Tolerability, Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in Subjects With Negative Symptoms and Cognitive Deficits of SchizophreniaStatus unknownNCT00685321Not applicable
• Omega-3 Fatty Acids and/or Multi-domain Intervention in the Prevention of Age-related Cognitive DeclineCompletedNCT00672685Not applicable
• RIVastigmine In Vascular cognitivE ImpairmentCompletedNCT00669344Phase 4
• Rehabilitation Program for Cognitive Deficits in Ugandan Children After Cerebral MalariaCompletedNCT00658450Not applicable
• System-IGF-1 Pathway and Alzheimer's DiseaseCompletedNCT00647478
• Recollection Training in Healthy Older Adults and Older Adults With Amnestic Mild Cognitive ImpairmentCompletedNCT00643266Not applicable
• Preliminary Study of Fish Oil and DementiaCompletedNCT00628017Not applicable
• GABA-glutamate Interactions and PsychosisCompletedNCT00611572Phase 1
• Effects of Cognitive Intervention for Older Adults With Memory Decline: A Pilot StudyCompletedNCT00609427Phase 1
• Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With SchizophreniaStatus unknownNCT00604760Phase 2
• Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor SurvivorsCompletedNCT00594633Phase 1
• Effect of AQW051 in Patients With Memory ImpairmentTerminatedNCT00582855Phase 2
• A Study Of Adjunctive Treatment Of Cognitive Deficits In SchizophreniaCompletedNCT00567203Phase 1
• Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)CompletedNCT00567060Not applicable
• Home-Based Assessment for Alzheimer Disease PreventionCompletedNCT00546767Not applicable
• Effects of a Complex Cognitive Training in Mild Cognitive Impairment and Mild Alzheimer's DiseaseCompletedNCT00544856Not applicable
• The Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive ImpairmentStatus unknownNCT00544791Phase 2
• A Study of C105 on Cognitive Dysfunction in Persons With Multiple SclerosisCompletedNCT00529581Phase 2
• The Mental Activity and eXercise Trial for SeniorsCompletedNCT00522899Not applicable
• Postoperative Cognitive Dysfunction in Geriatric PatientsCompletedNCT00512200
• Elder Surgery - Functional Recovery Following Beta BlockadeCompletedNCT00507663Phase 4
• Postanesthesia Cognitive Recovery and Neuropsychologic ComplicationsStatus unknownNCT00507195
• The Activity Intervention for ChemobrainCompletedNCT00495703Phase 2
• Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of CancerCompletedNCT00490334
• Clinical Trial on Alzheimer Disease, Presbycusis and Hearing AidsCompletedNCT00488007Not applicable
• MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)CompletedNCT00482430Phase 2
• Cognitive Impairment in Parkinson's Disease Categorised in Accordance to Motor SymptomsCompletedNCT00476372
• An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.CompletedNCT00474513Phase 1
• Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in SchizophreniaStatus unknownNCT00469664Phase 4
• The SOMNUS Study: Sedative Optimization Via Monitoring Neurological StatusCompletedNCT00469482Not applicable
• Galantamine for Cognitive Deficits in SchizophreniaCompletedNCT00463879Phase 2/3
• Peer Support for Increasing Physical Activity in People With Serious Mental IllnessesCompletedNCT00458094Not applicable
• Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF PatientsCompletedNCT00449410Phase 4
• Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular InsufficiencyCompletedNCT00446485Phase 4
• Cognitive Impairment Following Sedation for Colonoscopy With Propofol, Midazolam and Fentanyl CombinationsCompletedNCT00446420Phase 4
• Exercise and Activities for Independent Living With Mild Cognitive Impairment (MCI)CompletedNCT00446394Not applicable
• SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)CompletedNCT00438568Phase 2
• Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive ImpairmentCompletedNCT00422981Phase 2
• Study to Evaluate Safety, Tolerability, and Effect of AL208 on Mild Cognitive Impairment Following Coronary Artery Bypass Graft SurgeryCompletedNCT00404014Phase 2
• The Effects and Cost-Effectiveness of an Integrated Multidisciplinary Approach for Psychogeriatric PatientsCompletedNCT00402311Not applicable
• Computer-Based Training in Patients With Post-Chemotherapy Cognitive ImpairmentCompletedNCT00387062Phase 1
• Computer-Based Therapy for Mild Cognitive ImpairmentCompletedNCT00319943Phase 1
• Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive ImpairmentStatus unknownNCT00306124Phase 4
• Trial of Memantine for Cognitive Impairment in Multiple SclerosisCompletedNCT00300716Phase 2/3
• An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of GalantamineCompletedNCT00297414
• Prospective Research in Memory Clinics (PRIME)CompletedNCT00297271
• Gastrodin Prevents Cognitive Decline Related to Cardiopulmonary BypassStatus unknownNCT00297245Phase 4
• Enhancing Care Coordination: Hospital to Home for Cognitively Impaired Older Adults and Their CaregiversCompletedNCT00294307
• The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)CompletedNCT00293176Phase 4
• Support Groups for Patients With Mild Cognitive Impairment and Their PartnersCompletedNCT00285753Phase 2
• Improvement in Memory With Plasticity-Based Adaptive Cognitive Training (IMPACT)CompletedNCT00283010Not applicable
• Memory Improvement With Docosahexaenoic Acid Study (MIDAS)CompletedNCT00278135Not applicable
• Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple SclerosisCompletedNCT00276341Phase 3
• Physicians' Health Study IICompletedNCT00270647Not applicable
• SMART: Somatotrophics, Memory, and Aging Research TrialCompletedNCT00257712Phase 2
• Magnetic Resonance Imaging (MRI) of Brain Iron in Neurodegenerative DiseaseCompletedNCT00249080
• Early Detection of Mild Cognitive Impairment in Individual PatientsCompletedNCT00243451
• Rosiglitazone Effects on Cognition for Adults in Later LifeStatus unknownNCT00242593Phase 2
• A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive ImpairmentCompletedNCT00240695Phase 3
• A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive ImpairmentCompletedNCT00236574Phase 3
• A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive ImpairmentCompletedNCT00236431Phase 3
• Cognitive Effects of Aerobic Exercise for MCI AdultsCompletedNCT00220467Phase 2
• An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive DeficitsCompletedNCT00219245Phase 4
• Methylene Blue for Cognitive Dysfunction in Bipolar DisorderCompletedNCT00214877Phase 3
• Interaction of Cobalamin Status With Nitrous Oxide in Relation to Postoperative Cognitive Changes in the ElderlyCompletedNCT00212147Not applicable
• The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in SchizophreniaTerminatedNCT00206947Phase 2
• Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment PatientsTerminatedNCT00202540Phase 2

← Cognitive Dysfunction overview